One in twenty newborns is born with a birth defect. How can we protect the future through American IVF technology?

2024-10-18 19:11:54，浏览量： 20次

 

In recent years, with the postponement of childbearing age and the influence of environmental factors, the birth defect rate in my country is about 5.6%. This figure means that one in twenty newborns faces the risk of birth defects. This phenomenon not only severely impacts the health of newborns but also brings significant psychological and economic burdens to families.

 

According to statistics from the Chinese Medical Association, the decline in female ovarian function is a natural rule, and male fertility also gradually decreases with age. The birth defect rate of offspring significantly increases for women over 35 and men over 40. Therefore, for families considering childbirth, age is an important factor affecting reproductive health. Data shows that the monthly pregnancy rate for women at 35 is about 15%, while at 40, this figure drops to less than 5%. For men, sperm quality significantly declines after age 40, with increased probabilities of abnormal sperm motility and morphology, thereby affecting pregnancy success rates.

 

With the advancement of medical technology, the emergence of preimplantation genetic diagnosis (PGD) technology provides a new solution for older couples and those carrying genetic diseases. PGD is an advanced reproductive technology aimed at helping couples screen for healthy embryos by detecting genetic abnormalities in embryos, effectively reducing the incidence of birth defects.

 

The application of third-generation IVF (IVF-PGT) has been widely promoted globally, especially in reproductive medical institutions in the United States, where it has become the preferred option for many older couples or families with a family history of genetic diseases. Through IVF-PGT, doctors can extract cells from multiple in vitro fertilization embryos for genetic testing, thereby selecting healthy embryos. This technology can detect not only common chromosomal abnormalities but also various genetic diseases, such as Down syndrome, hemophilia, and thalassemia, providing greater assurance for future babies.

 

Throughout the IVF-PGT process, doctors first cultivate multiple embryos using IVF technology, then extract cells for genetic analysis when the embryos reach a specific developmental stage, selecting healthy embryos for implantation into the mother's uterus. This process not only increases the success rate of embryo implantation but also significantly reduces the risk of birth defects, providing families with more hope for welcoming a healthy baby.

When facing fertility issues, appropriate childbearing is undoubtedly an effective way to reduce birth defects. However, with the increasing pressures of modern life and changes in reproductive concepts, more and more families are choosing to use medical means to extend their reproductive capabilities. Currently, IVF USA provides services such as American egg freezing and American IVF, with business expansion into Japan, Thailand, Mexico, Taiwan, Hong Kong, and other regions, closely collaborating with top IVF doctors worldwide. If you have any questions regarding IVF technology or preimplantation genetic diagnosis, feel free to consult us at any time. Dr. Nathan Zhang and his professional team will provide comprehensive support and assistance throughout your fertility journey, helping you successfully embark on a new chapter of a happy family.